Literature DB >> 31372799

How to Identify Common Variable Immunodeficiency Patients Earlier: General Practice Patterns.

Frederik V Ilkjær1,2, Line D Rasmussen3, Raquel Martin-Iguacel3, Lena Westh4, Terese L Katzenstein5, Ann-Brit E Hansen6, Thyge L Nielsen7, Carsten S Larsen4,8, Isik S Johansen3.   

Abstract

PURPOSE: Diagnostic delay is a major problem concerning common variable immunodeficiency (CVID). We aimed to determine the pattern of general practitioner (GP) consultations in individuals diagnosed with CVID within 3 years before the diagnosis and whether the risk of diagnosis was associated with the frequency of consultations or character of examinations.
METHODS: We conducted a nested case-control study, identifying 132 adult CVID patients and 5940 age- and gender-matched controls from national registers during 1997-2013. We used conditional logistic regression to calculate the odds ratios (OR) and 95% confidence intervals (95%CI).
RESULTS: The median number of consultations among individuals with CVID was more than twice that of the controls in all 3 years (3rd, 10; 2nd, 11.5; and 1st, 15.4 vs. 4). We found a statistically significant association between the number of consultations and the risk of a subsequent CVID diagnosis, independent of age and gender, but strongest in the individuals < 40 years. In the 3rd year before diagnosis, having 9-15 consultations compared with 1-4 was associated with an OR (95%CI) of 5.0 (2.3-10.9), 2.4 (1.1-5.4), and 1.3 (0.3-5.3) for those aged 18-40, 41-60, and > 60, respectively. Several examinations (i.e., blood tests for inflammation/infection and pulmonary function test) were associated with increased odds of a subsequent CVID diagnosis.
CONCLUSION: The risk of a CVID diagnosis was highly related to both the number of consultations and the character of examinations performed by the GP. CVID should be a differential diagnosis among patients with multiple consultations, especially in patients < 40 years old.

Entities:  

Keywords:  CVID; PID; consultations; diagnostic delay; indicators; primary health care

Mesh:

Year:  2019        PMID: 31372799     DOI: 10.1007/s10875-019-00666-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  General practice and primary health care in Denmark.

Authors:  Kjeld Møller Pedersen; John Sahl Andersen; Jens Søndergaard
Journal:  J Am Board Fam Med       Date:  2012-03       Impact factor: 2.657

2.  Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels.

Authors:  Vincenzo Graziano; Antonio Pecoraro; Ilaria Mormile; Giuseppe Quaremba; Arturo Genovese; Claudio Buccelli; Mariano Paternoster; Giuseppe Spadaro
Journal:  Clin Immunol       Date:  2017-03-25       Impact factor: 3.969

3.  Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

Authors:  Benjamin Gathmann; Nizar Mahlaoui; Laurence Gérard; Eric Oksenhendler; Klaus Warnatz; Ilka Schulze; Gerhard Kindle; Taco W Kuijpers; Rachel T van Beem; David Guzman; Sarita Workman; Pere Soler-Palacín; Javier De Gracia; Torsten Witte; Reinhold E Schmidt; Jiri Litzman; Eva Hlavackova; Vojtech Thon; Michael Borte; Stephan Borte; Dinakantha Kumararatne; Conleth Feighery; Hilary Longhurst; Matthew Helbert; Anna Szaflarska; Anna Sediva; Bernd H Belohradsky; Alison Jones; Ulrich Baumann; Isabelle Meyts; Necil Kutukculer; Per Wågström; Nermeen Mouftah Galal; Joachim Roesler; Evangelia Farmaki; Natalia Zinovieva; Peter Ciznar; Efimia Papadopoulou-Alataki; Kirsten Bienemann; Sirje Velbri; Zoya Panahloo; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

4.  The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008.

Authors:  B Gathmann; B Grimbacher; J Beauté; Y Dudoit; N Mahlaoui; A Fischer; V Knerr; G Kindle
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

5.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

6.  Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort.

Authors:  Reza Yazdani; Hassan Abolhassani; Fatemeh Kiaee; Sima Habibi; Gholamreza Azizi; Marzieh Tavakol; Zahra Chavoshzadeh; Seyed Alireza Mahdaviani; Tooba Momen; Mohammad Gharagozlou; Masoud Movahedi; Amir Ali Hamidieh; Nasrin Behniafard; Mohammamd Nabavi; Mohammad Hassan Bemanian; Saba Arshi; Rasol Molatefi; Roya Sherkat; Afshin Shirkani; Reza Amin; Soheila Aleyasin; Reza Faridhosseini; Farahzad Jabbari-Azad; Iraj Mohammadzadeh; Javad Ghaffari; Alireza Shafiei; Arash Kalantari; Mahboubeh Mansouri; Mehrnaz Mesdaghi; Delara Babaie; Hamid Ahanchian; Maryam Khoshkhui; Habib Soheili; Mohammad Hossein Eslamian; Taher Cheraghi; Abbas Dabbaghzadeh; Mahmoud Tavassoli; Rasoul Nasiri Kalmarzi; Seyed Hamidreza Mortazavi; Sara Kashef; Hossein Esmaeilzadeh; Javad Tafaroji; Abbas Khalili; Fariborz Zandieh; Mahnaz Sadeghi-Shabestari; Sepideh Darougar; Fatemeh Behmanesh; Hedayat Akbari; Mohammadreza Zandkarimi; Farhad Abolnezhadian; Abbas Fayezi; Mojgan Moghtaderi; Akefeh Ahmadiafshar; Behzad Shakerian; Vahid Sajedi; Behrang Taghvaei; Mojgan Safari; Marzieh Heidarzadeh; Babak Ghalebaghi; Seyed Mohammad Fathi; Behzad Darabi; Saeed Bazregari; Nasrin Bazargan; Morteza Fallahpour; Alireza Khayatzadeh; Naser Javahertrash; Bahram Bashardoust; Mohammadali Zamani; Azam Mohsenzadeh; Sarehsadat Ebrahimi; Samin Sharafian; Ahmad Vosughimotlagh; Mitra Tafakoridelbari; Maziar Rahim; Parisa Ashournia; Anahita Razaghian; Arezou Rezaei; Ashraf Samavat; Setareh Mamishi; Hossein Ali Khazaei; Javad Mohammadi; Babak Negahdari; Nima Parvaneh; Nima Rezaei; Vassilios Lougaris; Silvia Giliani; Alessandro Plebani; Hans D Ochs; Lennart Hammarström; Asghar Aghamohammadi
Journal:  J Allergy Clin Immunol Pract       Date:  2018-09-19

7.  Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies.

Authors:  Stefano Tabolli; Patrizia Giannantoni; Federica Pulvirenti; Fabiola La Marra; Guido Granata; Cinzia Milito; Isabella Quinti
Journal:  Front Immunol       Date:  2014-11-26       Impact factor: 7.561

8.  Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Brian N McCullagh; Alejandro P Comellas; Zuhair K Ballas; John D Newell; M Bridget Zimmerman; Antoine E Azar
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

9.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

Review 10.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

View more
  2 in total

1.  Serum Protein Electrophoresis May Be Used as a Screening Tool for Antibody Deficiency in Children and Adolescents.

Authors:  Cristina Frias Sartorelli de Toledo Piza; Carolina Sanchez Aranda; Dirceu Solé; Stephen Jolles; Antonio Condino-Neto
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

2.  Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999.

Authors:  Marcin Ziętkiewicz; Ewa Więsik-Szewczyk; Aleksandra Matyja-Bednarczyk; Katarzyna Napiórkowska-Baran; Zbigniew Zdrojewski; Karina Jahnz-Różyk
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.